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Abstract: The study examined the factors affecting the decision to be vaccinated against 
influenza among employees in Israel. The research, conducted in 2007/2008, included 616 
employees aged 18−65 at various workplaces in Israel, among them companies that offered 
their  employees  influenza  vaccination.  The  research  questionnaire  included  
socio-demographic  characteristics,  and  the  Health  Belief  Model  principles.  The  results 
show that the significant factors affecting vaccination compliance include a vaccination 
program  at  workplaces,  vaccinations  in  the  past,  higher  levels  of  vaccine's  perceived 
benefits,  and lower levels of barriers to getting the vaccine. We conclude that vaccine 
compliance is larger at companies with workplace vaccination programs providing easier 
accessibility to vaccination. 
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1. Introduction 
Influenza is a prevalent and highly contagious disease that each year results in increased morbidity 
and mortality on a global scale. Because of the widespread nature of this disease, annual influenza 
epidemics cause substantial workplace absenteeism, and the associated cost of lost productivity is a 
significant component of the considerable financial burden this disease places on employers and on 
society [1-3]. Workplace vaccination programs against influenza have been found to be cost-effective 
from the points of view of society and of employers [4-6]. Nevertheless, to the best of our knowledge 
the effect of workplace vaccination programs on vaccination compliance among employees has not yet 
been examined. The current study fills this void. 
This study empirically examined the factors affecting: (a) the decision to be vaccinated against 
influenza  in  2006/2007,  and  (b)  the  intention  to  be  vaccinated  in  the  coming  12  months  among 
employees in Israel. The study focused on employees at workplaces that offered the vaccine to their 
employees and on those that did not offer their employees the vaccine. More specifically, we tested  
the following: 
a.  The impact of offering vaccination at workplaces on the decision to be vaccinated. 
b.  The impact of several other factors on the decision to be vaccinated. These factors include the 
Health  Belief  Model  (HBM)  [7]  categories,  such  as  perceived  susceptibility  to  influenza, 
perceived  severity  of  influenza,  perceived  benefits  of  the  vaccine,  and  barriers  to  getting 
vaccinated. In addition, we examine socio-demographic characteristics, and personal factors 
such as perceived heath status, perceived risk of illness, and perceived vaccine cost. 
c.  Main reasons for accepting or rejecting flu shots by employees in 2006/2007. 
The paper is organized as follows: Section 2 presents the literature review, Section 3 describes the 
model,  and  Section  4  describes  the  methods.  Section  5  presents  the  major  results,  and  Section  6 
summarizes the conclusions. 
2. Literature Review 
Several  recent  studies  have evaluated the economic burden of influenza on society, taking into 
account workplace absenteeism and the associated costs of lost productivity [1-3,8]. For example, in 
2008 Keech and Beardsworth reviewed a number of studies in an attempt to quantify the impact of 
influenza  upon  otherwise  healthy  adults  in  terms  of  lost  work  days  associated  with  an  influenza 
episode.  These  studies,  which  involved  study  sites  in  North  America,  Western  Europe,  Asia  and 
Australia, generally showed that the mean number of work days lost ranged between 1.5 and 5.9 days 
per influenza episode. The review highlights the significant economic impact of influenza, i.e., the loss 
of productivity caused by absenteeism as well as by employees functioning at reduced capacity even 
after they returned to work. 
Influenza vaccination has been shown to be cost effective in reducing morbidity, work absenteeism, 
and use of healthcare resources among the healthy working adult population [8-10]. Vaccine prevents 
influenza in approximately 70%90% of healthy adults under the age of 65 [9,11]. Several studies 
evaluating the health and economic benefits of a workplace vaccination program against influenza Int. J. Environ. Res. Public Health 2010, 7                 
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show that workplace vaccination of healthy adults against influenza has a clear impact on rates of 
influenza-like  illness  (ILI),  absenteeism,  and  reduced  company  productivity.  These  health  benefits 
translate into financial benefits for the employer, with cost savings significantly outweighing the costs 
of the vaccination program [4-6,12]. 
Based on several models published in the literature, Olsen et al. (2005) [5] calculated that estimated 
savings  per  healthy  working  adult  employee  could  be  anticipated  to  range  from  $15  to  $50  US. 
Variations in this net savings are based primarily on assumptions of employee productivity estimates. 
In addition, efficient influenza immunization programs at large worksites are feasible and worthy of 
employer consideration for economic reasons as well as for reasons of employee satisfaction. 
Several studies have examined factors affecting the decision to get the flu vaccine using the Health 
Belief  Model  (HBM)  [7]  as  a  conceptual  framework  to  examine  preventive  behavior  (e.g., 
vaccination). The HBM explains and predicts preventive health behavior in terms of belief patterns 
focusing on the relationship between health behaviors and utilization of health services. According to 
the  HBM,  getting  vaccinated  against  influenza  depends  on  the  following  predictors:  perceived 
susceptibility to influenza, beliefs about severity of influenza, perceived benefits of the vaccine in 
preventing influenza, and perceived barriers to getting vaccinated [13-15]. Indeed, cited reasons for not 
getting  influenza  vaccination  were  similar  across  studies  with  respect  to  perceived  barriers,  i.e., 
concern about side effects or vaccine safety, lack of vaccine effectiveness in preventing illness, and 
lack of awareness [13,15-18]. Our study is partially based on the HBM framework as implemented for 
employees in Israel.  
Socio-demographic  background,  economic  status,  and  health  status  are  also  known  to  have  an 
impact on an individual’s decision to get vaccinated [19,20]. In an empirical study conducted in the 
USA,  Wu  (2003)  found  that  people  with  more  education,  higher  incomes,  and  better  insurance 
coverage  are  more  likely  to  get  flu  shots,  as  well  as  various  other  types  of  preventive  medical 
treatments.  In  addition,  several  studies  have  shown  that  individuals’  risk  perceptions  predict  their 
subsequent vaccination against influenza, meaning that a higher perceived likelihood of becoming ill is 
associated with greater tendencies to get vaccinated [21-23]. It was also found that past experience 
with influenza vaccination is a predictor for willingness to get vaccinated [24], since those who were 
vaccinated previously may continue to do so annually as a matter of routine. 
The current study examined the factors affecting the decision to get vaccinated against influenza 
among  employees  in  Israel.  In  particular,  we  examined  the  impact  of  offering  vaccination  at 
workplaces on the decision to be vaccinated. 
3. The Model 
Using  regression  equations  for  the  analytical  model,  we  examined  the  factors  affecting  the 
vaccination status against influenza in 2006/2007 and the intention to be vaccinated in the coming 12 
months. The analytical model examines the effect of each one of the explanatory variables on the 
dependent variables, controlling for all other variables including socio-demographic characteristics.  Int. J. Environ. Res. Public Health 2010, 7                 
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The following equations describe the analytical model: 
 
Y1 =  +  1  HBM1 +  2   HBM2 + 3   HBM3 +  4   HBM4 + 1   RISK + 2  COST 
        +  3  HEALTH +  4  RECOM +  1  HMOTIV + 2   KNOW + 3  OFFER +  1  Gender      
        + 1  Age +  u 
( 1 )  
Y2 =  +  1  HBM1 +  2   HBM2 + 3   HBM3 +  4   HBM4 + 1   RISK + 2  COST 
        +  3  HEALTH +  4  RECOM +  1  HMOTIV + 2   KNOW + 3  OFFER +  1  Gender  
        + 1  Age +  u 
( 2 )  
 
In the first equation, the dependent variable, Y1, is the vaccination status in 2006/2007 (yes or no), 
and in the second equation, the dependent variable, Y2 is the intention to be vaccinated in the next 12 
months (intend or not intend). The explanatory variables include:
 
 
HBM categories:  
o  (a) HBM1—perceived susceptibility to influenza: Individuals at the low end of the susceptibility 
spectrum deny the possibility of contracting the illness, while those at the high end feel they are 
in real danger of contracting influenza.  
o  (b) HBM2—perceived severity of influenza: This category describes the level of an individual’s 
beliefs concerning the potential difficulties caused by influenza, such as pain and discomfort. 
o  (c) HBM3—perceived benefits of the vaccine: This category describes the level of an individual’s 
beliefs concerning what he or she stands to gain by getting the flu shot. 
o  (d) HBM4—perceived barriers to getting vaccinated: This category describes the level of an 
individual’s beliefs concerning potential difficulties caused by the vaccine, such as inconvenience 
and unpleasantness.  
We expected that intention to be vaccinated and vaccination status would be positively affected by 
higher levels of susceptibility, severity, and benefits (HBM1-HBM3), and negatively affected by higher 
levels  of  barriers  (HBM4)  [13].  Following  previous  studies  [15,19,24]  we  added  the  following 
subjective and personal factors as explanatory variables:   
Subjective  and  personal  factors:  RISK—perceived  risk  of  infection  if not  vaccinated;  COST— 
perceived cost of vaccination; HEALTH—perceived health status (bad, good); RECOM—whether or 
not  the  vaccine  was  recommended  by  physician,  family  or  friends;  HMOTIV—health  motivation, 
referring to degree of motivation for other health behaviors; KNOW—knowledge about influenza and 
the vaccine; OFFER—whether or not the vaccine was offered at the workplace. We expected that 
higher levels of perceived infection risk, perceived cost of vaccination, health motivation, knowledge 
and vaccination recommendation would positively affect an individual’s intention to be vaccinated and 
his  or  her  vaccination  status  (based  on  Shahrabani  et  al.,  2009  results  with  respect  to  nurses  in  
Israel [15]). In addition, we expected the intention to be vaccinated and the vaccination status to be 
higher for employees whose workplaces offer the vaccine.  
Socio-demographic factors: including gender and age groups. Int. J. Environ. Res. Public Health 2010, 7                 
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4. Methods 
4.1. Design 
A cross-sectional design research methodology was adopted, covering the period from November 
2007 to March 2008. The study population included 616 employees at various workplaces in Israel, 
ranging in age from 18 to 65 years old. We chose thirteen organizations from various industries in 
Israel. According to the main study question, we included two types of companies from each type of 
industry: companies that offered influenza vaccination to their employees in 2006/2007 and those that 
did not offer the vaccine to their employees. The organizations were: (a) five traditional industrial 
plants including the refinery complex, and the petrochemical complex, both offering the vaccine to 
their employees, the electricity company and the petrol and energy company, which did not offer the 
vaccine, (b) four service organizations including a higher education institution and an engineering 
services firm, both offering the vaccine, and an industrial supply services firm and another engineering 
services  firm  that  did  not  offer  the  vaccine,  (c)  two  large  international  high-tech  organizations 
including  optical  products  company,  which  offered  the  vaccine,  and  an  information  technologies 
company, which did not offer the vaccine. The study was approved by the Ethics Committee of the 
Max Stern Academic College of Emek Yezreel. 
4.2. Measures 
The research questionnaire was partially based on the questionnaire developed by Blue and Valley 
(2002) [13] and on its Hebrew version implemented for health care employees [15]. The final version 
of  the  questionnaire  was  finalized  after  analyzing  data  of  a  pilot  questionnaire  distributed  at  
two workplaces.  
The  questionnaire  consisted  of  the  following  parts:  (1)  items  requesting  socio-demographic 
information, including age, marital status, education, nationality, experience at work, and membership 
in a particular Health Maintenance Organization (henceforth, HMO); (2) whether the respondent had 
been vaccinated against influenza (yes or no) in the last year; (3) the intention to be vaccinated in the 
next 12 months, and the intention to be vaccinated if the flu shot is offered free of charge at the 
respondent’s place of work, on a 5-point scale ranging from 1 (―certainly I will get the vaccine in the 
next year‖) to 5 (―I will definitely not get the vaccine in the next year‖); (4) reasons for getting or not 
getting vaccinated, and place of vaccination for those who took the flu shot; (5) past flu vaccination 
history, and perceived health status (ranging from 1-―very good‖ to 4-―poor‖); (6) perceived probability 
of contracting influenza without the vaccine and after getting the vaccine (5-point scale ranging from 
1-―very high‖ to 5-―very low‖); (7) items measuring the HBM variables, including the four categories 
of susceptibility, seriousness, benefits, and barriers, as well as the categorical variables of knowledge 
and health motivation (see Table 1a in the Appendix). Items in the HBM predictor categories were 
measured on a 5-point Likert-type scale, with the following possible responses: strongly agree (1), 
agree (2), neither agree nor disagree (3), disagree (4), and strongly disagree (5). Each scale was defined 
as a sum of separate questions, with the sign of a correlation coefficient between the question and the 
scale divided by the number of the questions.   Int. J. Environ. Res. Public Health 2010, 7                 
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4.3. Data Collection Procedure 
The envelopes with the questionnaires and cover letters were randomly distributed among several 
departments, both in companies that had offered vaccination to their employees during 2006/2007 and 
in those that had not offered the vaccine. This procedure was carried out only after we asked the human 
resources department of each company to construct a sample made up of administrative as well as 
production employees, both genders and a range of ages.  
A cover letter was attached to the self-administered questionnaire form explaining the purpose of 
the study. In addition, the cover letter explained that participation in the study was voluntary and 
provided details of the researchers as well as instructions to return the completed questionnaire in the 
enclosed envelope to the human resource department via interoffice mail 
 (at each workplace where the 
human resources department gave formal permission to distribute the questionnaires to the employees 
on  a  voluntary basis).  Two weeks  later,  we contacted  the companies  and collected the completed 
questionnaires. In addition, to increase the number of participants from the high-tech industries, we 
distributed questionnaires (with cover letters) to 81 high-tech workers that were studying at the MBA 
program  in  the  Technion.  A  total  of  879  questionnaires  were  distributed  in  the  study,  and  616 
questionnaires were returned by the respondents, representing a response rate of 70.07%. This sample 
size provided power of 80% and more for the first main outcome (vaccination status in 2006–2007) for 
factors with OR 1.5 and more. For the second outcome (the intention to be vaccinated), this sample 
size provided the power of 80% for factors with OR more that 1.75 or 1.5 depending on the percent of 
exposed persons. 
4.4. Data Analysis 
The  statistical  package  STATA  10  SE  was  used  to  conduct  a  statistical  analysis  of  the  data.  
Chi-square tests were used to determine how selected categorical (e.g., gender) variables, including 
demographic factors, were related to the two dependent variables: (a) vaccination status in 2006/2007, 
and (b) intention to be vaccinated in the coming year. For an easier and more instructive interpretation, 
we  performed  a  binary  logistic  regression (and not  ordinal).  Therefore,  we transformed the initial  
5-point  Likert  scale  of  intention  to  be  vaccinated  into  a  binary  one:  the  dependent  variable  is  a 
dichotomous  variable  that is  equal  to  one if an individual said  that he/she  ―definitely intends‖ or 
―probably intends‖ to get a flu shot in the next year, and to zero for ―definitely do not intend‖, and 
―probably do not intend‖ (the answer ―do not know‖ was excluded).  
The  statistical  significance  of  the  difference  between  the  continuous  variable  means  (e.g.,  age, 
summary scales,  etc.) for two different groups (for example, for vaccinated  versus non-vaccinated 
participants) was determined by t-test. Multiple logistic regressions were conducted to identify the 
impact of demographic factors, factors derived from the HBM model, and other factors of interest 
regarding intention to be vaccinated and vaccination status in 2006/2007.  Int. J. Environ. Res. Public Health 2010, 7                 
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5. Results 
5.1. Descriptive Statistics 
In 2006/2007, 24% of the respondents reported they had been vaccinated against influenza (145 out 
of 616). Almost 68% of the employees that reported getting vaccinated in 2006/2007 said they had 
been vaccinated at a worksite program. Others (32%) got the vaccine from their family physician or at 
their HMO clinic.  
Table 1 summarizes the basic demographic information and characteristics for the sample according 
to vaccination status in 2006/2007. The table reveals that among the 568 participants (53% men and 
47% women), percentage of vaccinated employees in 06/07 was 30% for men and 18% for women  
(p value < 0.01). In addition, the percentage of vaccinated employees was higher among married versus 
unmarried individuals (27% and 15%, respectively, p value < 0.01), and among veteran Israelis versus 
new  immigrants  (arrival  after  1990)  (p  value  =  0.02).  The  table  also  indicates  an  increase  in 
vaccination rate with age (p value < 0.01) (49% among those aged 55 and over), an increase as the 
perceived cost of vaccination decreases (p value < 0.01), and an increase associated with increased 
perceived  self-risk  of  contracting  influenza  without  being  vaccinated  (p  value  <  0.01).  Moreover, 
among the 252 employees offered flu vaccination at work, 39% were vaccinated in 2006/2007, while 
only 12% of the 310 who were not offered the vaccine at work were vaccinated (p value < 0.01). The 
percentage of those vaccinated did not differ significantly among those with higher and lower levels  
of education. 
Table 1. Comparison of sample characteristics by vaccination status in 2006/2007. 
Vaccination status in 2006/2007       
p- Value  Yes (%)  No (%)  Number     
0.00  30  70  300  Male  Gender 
18  82  268  Female 
0.00  16  84  279  18−40  Age group 
  21  79  214  41−54 
49  51  110  55 + 
0.00  27  73  451  Married  Marital status 
15  85  155  Unmarried 
0.90  24  76  554  Jews  Nationality 
23  77  48  Other 
0.13  18  82  122  Secondary or below  Education 
24  76  472  Tertiary 
0.02  29  71  136  Before 1990  New immigrants  
11  89  44  (after 1990) 
0.00  0  100  337  never  Five-year influenza 
vaccination status   35  65  123  1−2 times 
88  12  105  3 and above 
0.00  39  61  252  Yes  Vaccine offered at 
workplace  12  88  310  No Int. J. Environ. Res. Public Health 2010, 7                 
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Table 1. Cont.  
0.00  28  72  53  expensive  Perceived cost of 
vaccination  35  65  164  cheap 
44  56  32  Free of charge 
13  87  319  Do not know 
0.00  44  56  148  high  Perceived risk of 
contracting influenza 
without vaccine 
19  81  334  Medium 
13  87  101  Low 
 
5.2. Main Reasons for Accepting or Rejecting Flu Shots 
Table 2 summarizes the main reasons indicated for accepting (Table 2a) or rejecting (Table 2b) the 
flu shot in 06/07. The results in Table 2 part (a) show that the top motivators for getting a flu-shot in 
2006/2007  were:  (a)  To  reduce  my  chances  of  contracting  influenza  (80%);  (b)  The  vaccine  was 
available  at  my  work  place  (35%);  (c)  Vaccination  was  recommended  to  me  (19%);  (d)  I  am 
accustomed to getting a flu shot each year (19%); (e) I do not want to miss any work because of 
influenza (19%). Respondents could select more than one reason. 
Table  2  part  (b)  also  shows  that  the  main  reasons  for  the  decision  not  to  take  the  vaccine  in 
2006/2007 were: (a) There are many strains of influenza (23%); (b) The vaccine is not effective (22%); 
(c) I do not believe in immunizations (21%); (d) I do not like injections (20%). In addition, it is 
interesting to note that 16% of the unvaccinated sample mentioned lack of time as one of the reasons 
for not getting vaccinated. Moreover, some of the reasons for rejecting the vaccine indicate a lack of 
knowledge about the vaccine among employees, including: ―The vaccine is not effective‖ (22%); ―The 
vaccine is not important‖ (18%); and ―The vaccine can cause influenza‖ (8%). 
Table 2. Main reasons for getting or rejecting flu shot in 2006/2007. 
b.  Reasons for rejecting flu shot * 
 (N = 483) 
a.  Reasons for getting flu shot*    
          (N = 195) 
% of 
unvaccinated 
employees 
selecting 
response 
Number of 
respondents 
selecting 
response 
Reasons for 
rejecting flu 
shot* 
% of 
vaccinated 
employees 
selecting 
response 
Number of 
respondents 
selecting 
response 
Reasons for 
getting flu shot* 
23  109  There are many 
strains of 
influenza 
80  156  To reduce my 
chances of getting 
influenza 
22  106  The vaccine is 
not effective 
35  69  The vaccine was 
available at my 
work place Int. J. Environ. Res. Public Health 2010, 7                 
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Table 2. Cont.  
21  100  Don’t believe in 
immunizations  
19  38  I do not want to 
miss any work 
because of 
influenza 
20  98  Do not like 
injections 
19  37  I got a 
recommendation 
18  85  The vaccine is 
not important 
19  37  I am accustomed 
to getting a flu 
shot each year 
16  79  No time to get the 
vaccine 
18  35  Not to transfer 
the illness to 
other people 
15  74  Potential side 
effect 
8  16  The  flu shot was 
free of charge 
15  71  I am not afraid of 
influenza 
7  14  I am over 65 
and/or have a 
chronic illness 
12  58  I do not need the 
vaccine since I do 
not suffer from 
chronic illness 
4  7  I was afraid of 
Avian influenza 
8  40  The vaccine can 
cause influenza 
2  2  Other reason  
* Respondents could select more than one reason. 
 
5.3. Effect of Offering Vaccination at Workplace on Intention to Get Flu Shot  
Table 3 shows intention to be vaccinated in the coming year if offered at work among employees 
who were not offered the vaccine at work the previous year. The results indicate that 36% percent of 
the 264 employees who were not vaccinated in 2006/2007 and not offered the vaccine at work said 
they intend to be vaccinated in the next year if the vaccine is offered to them at work. In addition, 30% 
of them said they are not sure whether or not they will get vaccinated next year if the vaccine is offered 
at work, though it is reasonable to assume that some of them will eventually get vaccinated.  
Moreover, according to Table 3, 23% of the 133 employees who declared that in general they do not 
intend to be vaccinated during the next 12 months indicated that if the vaccine is offered at their place 
of work, they will be vaccinated during the coming year. In other words, these results indicate that the 
incentive  to  get  vaccinated  is  substantially  higher  when  the  vaccine  is  available  at  workplaces  
than otherwise.  
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Table 3. Intention to get vaccinated if vaccine is offered at workplace, for those where 
vaccine was not offered at workplaces.  
        Intend to get the vaccine if the vaccine is 
offered at workplace* 
    N  %  Yes (%)  No (%)  Do not know (%) 
Vaccination 06/07 
 
No  264  100  36  34  30 
Yes  36  100  75  14  11 
Intention to get vaccinated in the 
next 12 months 
No  133  100  23  18  59 
Yes  72  100  86  7  7 
* For employees that were not offered the vaccine at work in 2006/2007. 
 
5.4. Results for HBM Categories 
 
Table 4 shows the mean values of the HBM model categories and the category variables (defined in 
Appendix 1a) as indices on a 5-point Likert scale (the scale for HBM categories ranged from ―strongly 
agree‖-1, to ―strongly disagree‖-5) measured by vaccination status in 2006/2007 and by intention to be 
vaccinated. The Cronbach’s alpha coefficients for the HBM categories were: perceived susceptibility 
(HBM1) −0.654, perceived seriousness (HBM2) −0.628, perceived benefits (HBM3) −0.686, perceived 
barriers (HBM4) −0.723, and health motivation −0.601.  
As  expected,  the  results  in  Table  4  indicate  that  for  individuals  who  had  been  vaccinated  in 
2006/2007, the levels of the following five categories were significantly lower than these levels for the 
non-vaccinated  group:  susceptibility  (2.98  vaccinated,  3.2  non-vaccinated);  seriousness  (1.92 
vaccinated, 2.15 non-vaccinated) benefits (2.56 vaccinated, 3.22 non-vaccinated), health motivation 
(2.56 vaccinated, 2.64 non-vaccinated), and knowledge (3.01 vaccinated, 3.43 non-vaccinated). The 
barriers category was significantly higher for the vaccinated than for the non-vaccinated group (3.89 
and 3.26, respectively). Similar differences in HBM categories were obtained between the group that 
intends to be vaccinated the next year and the group that does not intend to get a flu shot in the coming 
year. Therefore, on average vaccinated individuals perceived influenza as a more serious illness than 
did those who were not vaccinated. In addition, vaccinated individuals felt they were more susceptible 
to illness, perceived more benefits from vaccination, and had fewer barriers to getting the flu shot than 
did  the  non-vaccinated  employees.  Moreover,  on  average  the  vaccinated  individuals  were  more 
knowledgeable regarding the vaccine and influenza and had higher levels of health motivation. The 
same conclusions hold for the differences between the group of employees that intended to get the 
vaccine  in  the  next  year  and  the group that did  not  intend to  do so.  In general,  these results  are 
compatible with previous studies that referred to health care employees [13,15]. 
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Table 4. Mean values of Health Belief Model (HBM) measures by vaccination in 2006 or 
2007, and by intention to be vaccinated in the next year. 
Scale*  Vaccinated 
 
Non-vaccinated  t test 
(P value) 
Intend to get 
vaccinated 
Do not intend 
to get 
vaccinated 
t test 
(P value) 
N  Mean 
(SD) 
N  Mean 
(SD) 
N  Mean 
(SD) 
N  Mean 
(SD) 
Susceptibility   141  2.98 
 (0.06) 
461  3.20 
(0.04) 
2.95 
(0.00) 
200  2.90 
(0.05) 
244  3.33 
(0.05) 
5.30 
(0.00) 
Seriousness  143  1.92 
(0.05) 
467  2.15 
(0.03) 
3.60 
(0.00) 
200  1.90 
(0.04) 
245  2.24 
(0.05) 
5.08 
(0.00) 
Benefits  145  2.56 
 (0.06) 
470  3.22 
(0.03) 
9.53 
(0.00) 
201  2.55 
(0.05) 
246  3.46 
(0.04) 
14.0 
(0.00) 
Barriers  142  3.89 
(0.05) 
461  3.26 
(0.03) 
−10.01 
(0.00) 
199  3.69 
(0.05) 
241  3.21 
(0.04) 
−6.56 
(0.00) 
Health 
Motivation 
141  2.50 
(0.06) 
464  2.64 
(0.03) 
1.99 
(0.04) 
199  2.44 
(0.04) 
242  2.69 
(0.04) 
3.32 
(0.00) 
Knowledge 
  
140  3.01 
(0.07) 
459 
3.43 
(0.04) 
4.66 
(0.00) 
198  3.01 
(0.06) 
240 
3.54 
(0.05) 
5.86 
(0.00) 
* The 5-point scale for the HBM categories ranged from ―strongly agree‖ (1) to ―strongly disagree‖ (5). 
 
5.5. Results of the Analytical Model  
The analytical model examines the effect of each one of the explanatory variables on the dependent 
variable, controlling for all other variables including the socio-demographic characteristics. Table 5 
presents  the  results  of  the  logistic  model  regressions.  In  Table  5(a),  the  dependent  variable  is  a 
dichotomous variable that is equal to one if the individual had a flu shot in 2006/2007 and to zero if 
not. In Table 5(b), the dependent variable is a dichotomous variable that is equal to one if an individual 
said that he/she ―definitely intends‖ or ―probably intends‖ to get a flu shot in the next year, and to zero 
for  ―definitely  do  not  intend‖,  and  ―probably  do  not  intend‖.  The  analysis  of  ―intention  to  be 
vaccinated‖ was performed among those who did not take the flu shot in 2006/2007, since we found 
that the vaccination status in 2006/2007 was the strongest predictor of the intention to get the vaccine 
in 2008 (124 out of 141 subjects vaccinated in 2006/2007 said that they intend to get the flu shot in 
2008, versus only 77 out of 455 that were not vaccinated in 06/07 and said that they intend to take it in 
2008 (OR = 35.8 95%, CI = (19.9, 66.6)).  
The independent variables in parts (a) and (b) are: age group (less than 41, 41–55, 56 and above), 
gender, health status, whether or not the vaccine was recommended to the individual, perceived cost of 
vaccination,  whether  or  not  the  vaccine  was  offered  at  work,  perceived  infection  risk  without 
vaccination (high, medium, low), knowledge about influenza and the vaccine, and HBM categories.  
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Table 5. Results of logistic regression for dependent variables: (a) vaccination status in 
2006/2007, and (b) intention to get vaccinated in 2008 for those who did not take the 
vaccine in 2006/2007. 
        Dependent variable 
 
 
Explanatory variables 
  (a) Vaccination 06-07  
 (N = 538, Pseudo R
2 = 0.40) 
(b) Intention to get vaccinated 
(N = 395, Pseudo R
2 = 0.43)  
    OddsRatio  Std.Err.  P > |z|  OddsRatio  Std.Err.  P > |z| 
Age group  
Base (less than 41) 
Age 
group 2 
(41−55) 
0.80  0.27  0.52  0.57  0.19  0.11 
  Age 
group 3 
(56+) 
3.08  1.07  0.00  1.04  0.45  0.91 
Gender 
(base = male)  
 Female  0.58  0.17  0.06  0.74  0.23  0.34 
Perceived cost of 
vaccination 
  0.83  0.10  0.17  0.95  0.13  0.72 
Vaccine 
recommendation  
(base = recommended) 
  1.21  0.34  0.50  1.21  0.35  0.50 
Vaccination offered at 
work  
(base = not offered) 
Offered  5.71  1.78  0.00  2.52  0.75  0.00 
Perceived infection 
risk without 
vaccination  
(base = high risk) 
Medium 
risk 
0.38  0.12  0.00  0.39  0.14  0.01 
  Low risk  0.31  0.15  0.01  0.09  0.05  0.00 
Health status 
(base = good) 
Not 
good 
1.47  0.79  0.46  2.40  1.50  0.16 
HBM1-Susceptibility**     0.88  0.18  0.56  1.04  0.25  0.86 
HBM2-Seriousness**    0.80  0.16  0.27  0.65  0.13  0.04 
HBM3-Benefits**     0.38  0.07  0.00  0.18  0.04  0.00 
HBM4-Barriers**    3.52  0.89  0.00  2.43  0.64  0.00 
Health motivation    0.85  0.16  0.41  0.68  0.14  0.07 
Knowledge     0.82  0.12  0.20  0.69  0.11  0.03 
** For covariates being considered as continuous, the OR is for increment of the variables by 1. 
 
The  results  in  Table  5a  (columns  3–5)  show  that  the  significant  factors  positively  affecting 
vaccination status in 2006/2007 are: (a) whether the vaccine was offered at workplace: with vaccine 
offered at workplace increasing the odds of employees getting the vaccine by 5.7; (b) employee age: 
the odds of an employee aged 56 and up getting vaccinated are three-times higher than for an employee Int. J. Environ. Res. Public Health 2010, 7                 
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aged less than 41, (c) higher perceived risk of infection without vaccination, (d) HBM3—higher levels 
of perceived benefits, and (e) HBM4—lower levels of perceived barriers . 
The results in Table 5b (columns 6–8) show that the same significant factors affect the intention to 
get the vaccine in the next year as those affecting vaccination status in 2006/2007 (except for the age 
group variable). In addition, we found that higher levels of perceived seriousness of influenza (HBM2) 
and  greater  knowledge  about  the  illness  and  the  vaccine  increase  the  odds  of  intention  to  get  
the vaccine. 
To test the robustness of the results, we analyzed equations (1) and (2) simultaneously, (meaning a 
joint  analysis  for  the  two  dependent  variables:  the  intention  to  be  vaccinated  and  the  status  of 
vaccination in 2006–2007). The results of this analysis, not shown in the paper, indicated that the set of 
coefficients and significant predictors are very similar to the predictors that we found in the separate 
equations analysis.  
Using additional logistic regression, we also examined the effect of past vaccination (number of 
vaccinations during the years 2002–2005) on vaccination status (data not shown here). The results 
indicate that the odds of being vaccinated increase significantly with higher perceived benefits, lower 
perceived barriers, vaccine offered at workplace, and higher number of vaccination during the years 
2002–2005. Yet, we did not find any significant effect of perceived infection risk or of age group on 
employees’  vaccination  status.  These  results  may  suggest  that  past  experience  with  the  vaccine 
dominates other possible reasons for deciding to get vaccinated, including age. People who had a good 
experience with the vaccine in the past may continue to be vaccinated routinely each year. Our result 
that past experience with the vaccine affects vaccination status is also compatible with the findings of 
Sendi et al. (2004).  
6. Summary and Conclusions 
Although  the  younger  working  population  is  less  prone  to  serious  illness  following  influenza 
infection, it has been shown that influenza vaccination may prevent illness, and therefore a transient 
loss in quality of life, and may reduce direct medical costs and productivity costs due to absence from 
work [8-10]. Workplace vaccination of healthy adults against influenza has had health benefits that 
translate into financial benefits for the employer, with cost savings significantly outweighing the costs 
of the vaccination program [4,6]. 
The current study examined the factors, and in particular workplace vaccination programs, affecting 
the decision to get vaccinated against influenza among employees in Israel. The results show that 
workplace  vaccination  programs  significantly  increase  influenza  vaccine  compliance  among 
employees. Offering the vaccine at worksites facilitates easier access to vaccination and reduces the 
overall costs, including the time wasted and the inconvenience of getting the vaccine at HMO clinics. 
In other words, a vaccination program reduces employee barriers to getting vaccinated.  
Although vaccination programs significantly increase compliance rates (39% at workplaces with 
vaccination program versus 12% at workplaces without such a program), vaccination rates are still 
quite low in the sample of the current study. As our findings indicate, this relatively low rate stems 
from low perceived vaccination benefits, high barriers to getting a flu shot (e.g., worry about side 
effects), and lack of knowledge about influenza and the vaccine. In line with the findings of [24], our Int. J. Environ. Res. Public Health 2010, 7                 
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results also show that past experience with the vaccine is a significant factor in employees’ decisions to 
get a flu shot. It may be that people who have had good experience with the vaccine in the past will 
continue to  be routinely vaccinated each year. Therefore, offering the vaccine at  workplaces  on a 
regular basis is important.  
In the light of the current research results, the following recommendations can be made: (a) to 
encourage vaccination programs at workplaces and in other public places, such as shopping centers 
(during the relevant season) at days and times convenient for working people; (b) to consider offering 
the vaccine free of charge to the entire population, since recent behavioral economics research has 
shown that people strongly react to free products and services [25]; (c) to offer an advertising campaign 
stressing the importance of vaccination. Key strategies for the success of such a campaign include 
providing employees with evidence-based information related to influenza and immunization using a 
variety of media [26]. Goldstein et al., 2004 suggested that tailored employee educational campaigns 
should  target  the primary reasons  for noncompliance with  vaccinations,  ―fear of side effects‖ and 
―perceived ineffectiveness of the flu vaccine‖, which show insufficient knowledge about the vaccine’s 
effectiveness and few side effects [27]. These recommendations are also in line with the findings of 
Kimura  et  al., (2007) [28], that the combination of a vaccine day at worksite and an educational 
campaign
 was most effective in increasing vaccine coverage of health care workers. In other words, 
multiple  strategies  used  in  concert  will  likely  achieve  higher  vaccination  rates  than  would  single 
strategies  alone.  Finally,  future  study  is  important  to  focus  on  factors  affecting  compliance  with 
essential vaccinations among different socio-demographic groups.  
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Appendix  
Table 1a. HBM categories and categorical variables*. 
Variables    Statements 
HBM Categories   Susceptibility   Working  with  many  people  each  day  increases  my 
chances of getting the flu 
My chances of getting the flu are good 
I worry a lot about getting the flu 
I will get the flu next year 
Seriousness 
 
Getting the flu would disrupt my family  
Having  the  flu  would  make  daily  activities  more 
difficult 
Flu can be a serious disease 
Benefits 
 
Getting a flu shot will prevent me from getting the flu 
Getting a flu shot will prevent me from missing work 
I would not be afraid of getting the flu if I got a flu 
shot 
Barriers 
 
Getting a flu shot can be painful 
Getting a flu shot is time consuming 
There are too many risks in getting a flu shot 
I am concerned about having a bad reaction to the flu 
shot Int. J. Environ. Res. Public Health 2010, 7                 
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Table 1a. Cont. 
Categorical 
variables  
Health Motivation 
 
I eat a well-balanced diet 
I follow medical orders because I believe they will 
benefit my state of health 
I search for new information related to my health 
I exercise regularly at least twice a week 
Knowledge  People often get sick from flu injections 
* The 5-point scale for the categories ranged from ―strongly agree‖ (1) to ―strongly disagree‖ (5). 
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